NPD licensing deal
This article was originally published in The Rose Sheet
Executive SummaryLicensing agreement with international fragrance expert Michael Edwards will enable NPD Beauty to use Edwards' copyright-protected fragrance system to provide clients data on consumer preference and the general olfactive trends, the NPD Group announces June 18. The technology classifies prestige fragrances according to a palette of 12 fragrance families, including citrus, green, water, floral and Oriental, company says. NPD clients will be able to assess which fragrance families are gaining market share, estimate performance based on scent type and track competitive performance, firm adds...
You may also be interested in...
ICER president Steve Pearson is ‘cautiously optimistic’ that net pricing for acute migraine treatments will align with benefits once discounts are factored in.
Almost 50 novel agents are already under review at FDA for potential 2020 approval. Candidates are notably diverse, with concentrations in established strongholds (oncology, neuroscience), popular programs (breakthrough), and powerhouse sponsors (keep an eye on Bristol-Myers Squibb right out of the gate).
CBER is starting the year with four novel gene and cell therapy applications under review and rolling submissions underway for more.